Cullinan Therapeutics Files Prospectus For Offering Mixed Shelf; Terms Undisclosed

Benzinga Newsdesk www.benzinga.com Neutral 93.4%

Neg 0% Neu 93.4% Pos 0%

https://www.sec.gov/Archives/edgar/data/1789972/000119312526183596/d587157ds3asr.htm

Comments

No comments yet. Be the first!